John King

John King is an accomplished executive with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as Chief Commercial Officer at Dianthus Therapeutics, Inc. since March 2025, John previously held similar roles at Vor Bio and Ra Pharmaceuticals. John’s tenure at Alexion Pharmaceuticals, Inc. spanned nearly a decade, where various leadership positions included VP roles for the US Neurology Business Unit and global franchises in rare diseases. Earlier in their career, John contributed to Pfizer's marketing efforts for Enbrel and gained experience at Accenture and Ernst & Young Global Consulting Services. John holds a Bachelor of Science in Business Logistics and a Master of Business Administration in Finance from Penn State University.